ParkinsonFranceV1, PubMed, Curation, bibRecord, 000452

Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?

Identifieur interne : 000452 ( PubMed/Curation ); précédent : 000451; suivant : 000453

Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?

Auteurs : Nagaraj D. Halemani [France]

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.

RBID : pubmed:25382254

English descriptors

KwdEn :
- Animals, Deep Brain Stimulation, Disease Models, Animal, Glutamic Acid (metabolism), Humans, Parkinson Disease (therapy), Subthalamic Nucleus (metabolism), Subthalamic Nucleus (physiopathology).
MESH :
- chemical , metabolism : Glutamic Acid.
- metabolism : Subthalamic Nucleus.
- physiopathology : Subthalamic Nucleus.
- therapy : Parkinson Disease.
- Animals, Deep Brain Stimulation, Disease Models, Animal, Humans.

DOI: 10.1002/mds.26074
PubMed: 25382254

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000461

Links to Exploration step

pubmed:25382254

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?</title>
<author><name sortKey="Halemani, Nagaraj D" sort="Halemani, Nagaraj D" uniqKey="Halemani N" first="Nagaraj D" last="Halemani">Nagaraj D. Halemani</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut des Maladies Neurodégénératives, Université Bordeaux Segalen, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut des Maladies Neurodégénératives, Université Bordeaux Segalen, Bordeaux</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25382254</idno>
<idno type="pmid">25382254</idno>
<idno type="doi">10.1002/mds.26074</idno>
<idno type="wicri:Area/PubMed/Corpus">000461</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000461</idno>
<idno type="wicri:Area/PubMed/Curation">000452</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000452</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?</title>
<author><name sortKey="Halemani, Nagaraj D" sort="Halemani, Nagaraj D" uniqKey="Halemani N" first="Nagaraj D" last="Halemani">Nagaraj D. Halemani</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut des Maladies Neurodégénératives, Université Bordeaux Segalen, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut des Maladies Neurodégénératives, Université Bordeaux Segalen, Bordeaux</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Deep Brain Stimulation</term>
<term>Disease Models, Animal</term>
<term>Glutamic Acid (metabolism)</term>
<term>Humans</term>
<term>Parkinson Disease (therapy)</term>
<term>Subthalamic Nucleus (metabolism)</term>
<term>Subthalamic Nucleus (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Glutamic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Deep Brain Stimulation</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25382254</PMID>
<DateCreated><Year>2014</Year>
<Month>12</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>09</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>12</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>29</Volume>
<Issue>14</Issue>
<PubDate><Year>2014</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?</ArticleTitle>
<Pagination><MedlinePgn>1757</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.26074</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halemani</LastName>
<ForeName>Nagaraj D</ForeName>
<Initials>ND</Initials>
<AffiliationInfo><Affiliation>Institut des Maladies Neurodégénératives, Université Bordeaux Segalen, Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber>
<NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D046690" MajorTopicYN="Y">Deep Brain Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020531" MajorTopicYN="N">Subthalamic Nucleus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>9</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25382254</ArticleId>
<ArticleId IdType="doi">10.1002/mds.26074</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000452 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000452 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25382254
   |texte=   Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25382254" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?

Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki